Medac Gesellschaft für klinische Spezialpräparate mbH (packaging, labelling and batch release)

The drug is used as monotherapy for patients with metastatic breast cancer (Stage IV) if previous chemotherapy has been ineffective or is unsuitable, as well as for the treatment of Stage III and IV non-small cell lung cancer.

Dosage form: concentrate for infusion solution

ATC: L01CA04